
Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2023, titled "NATCO records ₹1060.8 Crore consolidated revenue and ₹369 Croreof profit after tax, for the Second Quarter, FY2024".
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2023, titled "NATCO records ₹1060.8 Crore consolidated revenue and ₹369 Croreof profit after tax, for the Second Quarter, FY2024".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma